Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis

British Journal of Haematology

Volumn 120, Issue 3, 2003, Pages 464-470

  Abu Duhier, Faisel M ^a   Goodeve, Anne C ^a   Care, Rory S ^a   Gari, Mamdooh ^a   Wilson, Gill A ^a   Peake, Ian R ^a   Reilly, John T ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

c fms; c kit; FLT3; Idiopathic myelofibrosis; RTK class III

Indexed keywords

ASPARAGINE; ASPARTIC ACID; DNA; FLT3 LIGAND; GLYCINE; PROTEIN C FMS; PROTEIN TYROSINE KINASE; SERINE; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ARTICLE; C FMS GENE; C KIT GENE; CONFORMATION SENSITIVE GEL ELECTROPHORESIS; DNA SEQUENCE; ENZYME ANALYSIS; FLT3 GENE; GEL ELECTROPHORESIS; GENE ISOLATION; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; HUMAN; IDIOPATHIC DISEASE; INTRON; JAPAN; MYELOFIBROSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

DNA MUTATIONAL ANALYSIS; FMS-LIKE TYROSINE KINASE 3; GENES, FMS; HUMANS; MUTATION; MYELOFIBROSIS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0037323834     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04108.x     Document Type: Article

References (54)

1. Abu-Duhier, F.M., Goodeve, A.C., Wilson, G.A., Gari, M.A., Peake, I.R., Rees, D.C., Vandenberghe, E.A., Winship, P.R. & Reilly, J.T. (2000) FLT3 internal tandem duplication mutations in adult myeloid leukaemia define a high-risk group. British Journal of Haematology, 111, 190-195.
2. Abu-Duhier, F., Goodeve, A., Wilson, G., Care, R.S., Peake, I.R. & Reilly, J.T. (2001a) Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia. British Journal of Haematology, 113, 983-988.
3. Abu-Duhier, F.M., Goodeve, A.C., Wilson, G.A., Care, R.S., Peake, I.R. & Reilly, J.T. (2001b) Genomic structure of human FLT3: implications for mutational analysis. British Journal of Haematology, 113, 1076-1077.
4. Abu-Duhier, F., Goodeve, A.C., Wilson, G.A., Care, R.S., Peake, I.R. & Reilly, J.T. (2002) FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia. Blood, 100, 364.
5. Andre, C., Hampe, A., Lachaume, P., Martin, E., Wang, X.P., Manus, V., Hu, W.X. & Galibert, F. (1997) Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. Genomics, 39, 216-226.
6. Beghini, A., Peterlongo, P., Ripamonti, C.B., Larizza, L., Cairoli, R., Morra, E. & Mecucci, C. (2000) c-kit mutations in core binding factor leukemias. Blood, 95, 726-727.
7. Bowen, D.T., Padua, R.A., Burnett, A.K., deCastro, C.M. & Kaufman, R.E. (1993) Two new polymorphisms but no mutations of the kit gent in patients with myelodysplasia at positions corresponding to human fms and murine W locus mutational hot spots. Leukemia, 7, 1883-1885.
8. Carlo-Stella, C., Cazzola, M., Gasner, A., Barosi, G., Dezza, L., Meloni, F., Pedrazzoli, P., Hoelzer, D. & Ascari, E. (1987) Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E and CFU-GM) from patients with myelofibrosis with myeloid metaplasia. Blood, 70, 1014-1019.
9. Coussens, L., Van Beveren, C., Smith, D., Chen, E., Mitchell, R.L., Isacke, C.M., Verma, I.M. & Ullrich, A. (1986) Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature, 320, 277-280.
10. van Daalen Wetters, T., Hawkins, S.A., Roussell, M.F. & Sherr, C.J. (1992) Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain. EMBO Journal, 11, 551-557.
11. Gari, M., Goodeve, A., Wilson, G., Winship, P., Langabeer, S., Linch, D., Vandenberghe, E., Peake, I. & Reilly, J. (1999) c-kit protooncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia. British Journal of Haematology, 105, 894-900.
12. Gisselbrecht, S., Fichelson, S., Sola, B., Bordereaux, D., Hampe, A., Andre, C., Galibert, F. & Tambourin, P. (1987) Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature, 329, 259-261.
13. Hampe, A., Shamoon, B.M., Gobet, M., Sherr, C.J. & Galibert, F. (1989) Nucleotide sequence and structural organization of the human FMS proto-oncogene. Oncogene Research, 4, 9-17.
14. Han, Z.C., Briere, J., Nedellec, G., Abgrall, J.F., Senzebe, L., Parent, D. & Guern, G. (1988) Characteristics of circulating megakaryocyte progenitors (CKU-MK) in patients with myelofibrosis. European Journal of Haematology, 40, 130-135.
15. Hinks, J.L., Winship, P.R., Makris, M., Preston, F.E., Peake, I.R. & Goodeve, A.C. (1999) A rapid method for haemophilia B mutation detection using conformational sensitive gel electrophoresis. British Journal of Haematology, 104, 915-918.
16. Horiike, S., Yokota, S., Nakao, M., Iwai, T., Sasai, Y., Kaneko, H., Taniwaki, M., Kashima, K., Fujii, H., Abe, T. & Misawa, S. (1997) Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia. Leukemia, 11, 1442-1446.
17. Ishii, E., Zaitsu, M., Ihara, K., Hara, T. & Miyazaki, S. (1999) High expression but no internal tandem duplication of FLT3 in normal haematopoietic cells. Paediatric Hematology and Oncology, 16, 437-441.
18. Khazaie, K., Duff, T.J., Graf, T., Schlessinger, J., Ullrich, A., Beug, H. & Vennström, B. (1988) Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. EMBO Journal, 7, 3061-3071.
19. Kimura, A., Nakata, Y., Katoh, O. & Hyodo, H. (1997) c-kit mutations in patients with myeloproliferative disorders. Leukemia and Lymphoma, 25, 281-287.
20. Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., Akiyama, H., Saito, K., Oh, H., Motoji, T., Omoto, E., Saito, H., Ohno, R. & Ueda, R. (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood, 93, 3074-3080.
21. Kottaridis, P.D., Gale, R.E., Frew, M.E., Harrison, G., Langabeer, S.E., Belton, A.A., Walker, H., Wheatley, K., Bowen, D.T., Burnett, A.K., Goldstone, A.H. & Linch, D.C. (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukaemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood, 98, 1752-1759.
22. Lebowitz, P., Papac, R. & Ghosh, P.K. (1990) Impaired retinoblastoma susceptibility (Rb) gene expression in agnogenic myeloid metaplasia. Blood, 76, 236a.
23. Misawa, S., Horiike, S., Kaneko, H. & Kashima, K. (1997) Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome. Leukemia, 11, 533-535.
24. Morris, C.M., Cochrane, J.M., Benjes, S.M., Crossen, P.E. & Fitzgerald, P.H. (1991) Molecular definition of interstitial deletions of chromosome 13 in leukemic cells. Genes, Chromosomes and Cancer, 3, 455-460.
25. Nakano, Y., Kiyoi, H., Miyawaki, S., Asou, N., Ohno, R., Saito, H. & Naoe, T. (1999) Molecular evolution of acute myeloid leukemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene. British Journal of Haematology, 104, 659-664.
26. Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S., Kashima, K., Sonoda, Y., Fujimoto, T. & Misawa, S. (1996) Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia, 10, 1911-1918.
27. Nakata, Y., Kimura, A., Katoh, O., Kawaishi, K., Hyodo, H., Abe, K., Kuramoto, A. & Satow, Y. (1995) c-kit point mutation of extracellular domain in patients with myeloproliferative disorders. British Journal of Haematology, 91, 661-663.
28. Pagliuca, A., Layton, D.M., Manoharan, A., Gordon, S., Green, P.J. & Mufti, G.J. (1989) Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. British Journal of Haematology, 71, 499-504.
29. Paquette, R.L., Hsu, N.C. & Koeffler, H.P. (1996) Analysis of c-kit gene integrity in aplastic anaemia. Blood Cells, Molecules, and Diseases, 22, 159-168.
30. Rameshwar, P., Denny, T.N., Stein, D. & Gascon, P. (1994) Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta. Journal of Immunology, 153, 1810-1830.
31. Rameshwar, P., Chang, V.T. & Gascon, P. (1996) Implication of CD44 in adhesion-mediated overproduction of TGF-β and IL-1 in monocytes from patients with bone marrow fibrosis. British Journal of Haematology, 96, 22-29.
32. Reilly, J.T. (1999) Pathogenesis and management of idiopathic myelofibrosis. In: Myeloproliferative Disorders, Balliere's Clinical Haematology (ed. by A. Green & T.C. Pearson), 11.4, 751-767. Bailliere Tindall, London.
33. Reilly, J.T. (2002) Class III receptor tyrosine kinases: role in leukaemogenesis. British Journal of Haematology, 116, 744-757.
34. Reilly, J.T. & Dolan, G. (1991) Proposed classification for the myelodysplastic/myelofibrosis syndromes. British Journal of Haematology, 79, 653-659.
35. Reilly, J.T., Wilson, J., Barnett, D., Watmore, A. & Potter, A. (1994) Karyotypic and ras gene mutation analysis in idiopathic myelofibrosis. British Journal of Haematology, 88, 575-581.
36. Ridge, S.A., Worwood, M., Oscier, D., Jacobs, A. & Padua, R.A. (1990) FMS mutations in myelodyplastic, leukemic, and normal subjects. Proceedings of the National Academy of Sciences of the United States of America, 87, 1377-1380.
37. Riva, P. & Larizza, L. (1996) A novel potentially diagnostic polymorphism (4894A/C) in exon 10 of the human c-kit protooncogene. Molecular and Cellular Probes, 10, 387-388.
38. Rosnet, O., Schiff, C., Pébusque, M.-J., Marchetto, S., Tonnelle, C., Toiron, Y., Birg, F. & Birnbaum, D. (1993) Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood, 82, 1110-1119.
39. Shen, L.X., Basilion, J.P. & Stanton, V.P.J. (1999) Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proceeding of the National Academy of Sciences of the United States of America, 96, 7871-7876.
40. Shepherd, L., Cameron, C., Graham, C., Hoyle, S., Galbraith, P.R. & Lillicrap, D. (1990) Direct sequencing of the N-ras, c-fins and p53 loci for transforming mutations in myelomonocytic leukaemia. Blood, 76, 245a.
41. Siitonen, T., Savolainen, E.-R. & Koistinen, P. (1994) Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia, 8, 631-637.
42. Siitonen, T., Zheng, A., Savolainen, E.-R. & Koistinen, P. (1996) Spontaneous granulocyte-macrophage colony growth by peripheral blood mononuclear cells in myeloproliferative disorders. Leukaemia Research, 20, 187-195.
43. Siverstein, M.N., Brown, A.L. & Linman, J.W. (1973) Idiopathic myeloid metaplasia: its evolution into acute leukemia. Archives of Internal Medicine, 132, 709-712.
44. Springall, F., O'Mara, S., Shounan, Y., Todd, A., Ford, D. & Illand, H. (1993) c-fms point mutations in acute myeloid leukaemia: fact or fiction? Leukemia, 7, 978-985.
45. Spritz, R.A., Giebel, L.B. & Holmes, S.A. (1992) Dominant negative and loss of function mutations of the c-kit (mast/cell growth factor receptor) proto-oncogene in human piebaldism. American Journal of Human Genetics, 50, 261-269.
46. Titius, B.R., Thiele, J., Schaefer, H., Kreipe, H. & Fischer, R. (1994) Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages. Acta Haematologica, 91, 144-149.
47. Tobal, K., Pagliuca, A., Bhatt, B., Bailey, N., Layton, D.M. & Mufti, G.J. (1990) Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia, 4, 486-489.
48. Ullrich, A. & Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212.
49. Uren, A., Yu, J.C., Karcaaltincaba, M., Pierce, J.H. & Heidaran, M.A. (1997) Oncogenic activation of the alpha PDGFR defines a domain that negatively regulates receptor dimerization. Oncogene, 14, 157-162.
50. Williams, I.J., Abuzenadah, A., Winship, P.R., Preston, F.E., Dolan, G., Wright, J., Peake, I.R. & Goodeve, A.C. (1998) Precise carrier diagnosis in families with haemophilia A: use of conformational sensitive gel electrophoresis for mutation screening and polymorphism analysis. Thrombosis and Haemostasis, 79, 723-726.
51. Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., Akiyama, H., Saito, K., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Saito, H., Ueda, R., Ohno, R. & Naoe, T. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 97, 2434-2439.
52. Yarden, Y., Kuang, W.J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T.J., Chen, E., Schessinger, J., Francke, U. & Ullrich, A. (1987) Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO Journal, 6, 3341-3351.
53. Yarden, Y. & Ullrich, A. (1988) Growth factor receptor tyrosine kinase. Annual Review of Biochemistry, 57, 443-478.
54. Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matsuo, Y. & Naoe, T. (1997) Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia, 11, 1605-1609.